Canpolat, Sinan; Ulker, Nazife; Yardimci, Ahmet; Bulmus, Ozgur; Ozdemir, Gokcen; Sahin, Zafer; Ercan, Zubeyde; Serhatlioglu, Ihsan; Kacar, Emine; Ozcan, Mete; Turk, Gaffari; Ozkan, Yusuf; Atmaca, Murad; Yilmaz, Bayram; Kelestimur, Haluk
(2016-01-05)
Agomelatine is an antidepressant with a novel mechanism of action. It is a melatonergic agonist for MT1 and MT2 receptors and a serotonin (5-HT2C) receptor antagonist. Agomelatine has been suggested not to have adverse ...